The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
CCR2 Antagonism Alters Brain Macrophage Polarization and Ameliorates Cognitive Dysfunction Induced by Traumatic Brain Injury
Open accessAbstract
Traumatic brain injury (TBI) is a major risk factor for the development of multiple neurodegenerative diseases. With respect to the increasing prevalence of TBI, new therapeutic strategies are urgently needed that will prevent secondary damage to primarily unaffected tissue. Consistently, neuroinflammation has been implicated as a key mediator of secondary damage following the initial mechanical insult. Following injury, there is uncertainty regarding the role that accumulating CCR2 + macrophages play in the injury-induced neuroinflammatory sequelae and cognitive dysfunction. Using CX3CR1 GFP /+ CCR2 RFP /+ reporter mice, we show that TBI initiated a temporally restricted accumulation of peripherally derived CCR2 + macrophages, which were concentrated in the hippocampal formation, a region necessary for learning and memory. Multivariate analysis delineated CCR2 + macrophages' neuroinflammatory response while identifying a novel therapeutic treatment window. As a proof of concept, targeting CCR2 + macrophages with CCX872, a novel Phase I CCR2 selective antagonist, significantly reduced TBI-induced inflammatory macrophage accumulation. Concomitantly, there was a significant reduction in multiple proinflammatory and neurotoxic mediators with this treatment paradigm. Importantly, CCR2 antagonism resulted in a sparing of TBI-induced hippocampal-dependent cognitive dysfunction and reduced proinflammatory activation profile 1 month after injury. Thus, therapeutically targeting the CCR2 + subset of monocytes/macrophages may provide a new avenue of clinical intervention following TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Separate groups have shown that CCX872 and RS504393, two selective CCR2 antagonists, reduce post-injury macrophage recruitment and improve functional recovery after CCI and weight drop TBI (76, 77).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
Inflammation after trauma: Microglial activation and traumatic brain injury
Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22455 · Cited by 999
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration
Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674
Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C.-L., Ransohoff, R. M., & Charo, I. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013693 · Cited by 599
Research works printed but not linked: 48
- 10.1126/science.1142883 · DOI · Paper page
- 10.1146/annurev.immunol.021908.132557 · DOI
- 10.2119/2008-00050.Beauchamp · DOI
- 10.1016/j.bbi.2011.07.225 · DOI
- 10.1158/0008-5472.CAN-12-2989 · DOI
- 10.1172/JCI34613 · DOI
- 10.1016/j.expneurol.2006.10.013 · DOI
- 10.1016/j.neuroscience.2012.08.058 · DOI
- 10.1038/nprot.2006.327 · DOI · Paper page
- 10.1016/j.brainres.2012.08.032 · DOI
- 10.1007/s11481-009-9164-4 · DOI
- 10.1186/1479-5876-5-11 · DOI · Paper page
- 10.1371/journal.pone.0059712 · DOI
- 10.1136/jnnp.74.7.857 · DOI · Paper page
- 10.1523/JNEUROSCI.4070-13.2014 · DOI · Paper page
- 10.2174/157015912804499483 · DOI
- 10.1002/eji.201243084 · DOI
- 10.1096/fj.05-5465com · DOI
- 10.1089/neu.2008.0562 · DOI
- 10.1093/brain/aws322 · DOI · Paper page
- 10.1523/JNEUROSCI.3257-09.2009 · DOI · Paper page
- 10.1182/blood-2008-07-168575 · DOI · Paper page
- 10.1089/neu.2012.2589 · DOI
- 10.4049/jimmunol.166.7.4697 · DOI
- 10.4049/jimmunol.1100421 · DOI · Paper page
- 10.1523/JNEUROSCI.0539-12.2012 · DOI
- 10.1371/journal.pone.0093650 · DOI
- 10.1016/j.injury.2007.10.005 · DOI · Paper page
- 10.1089/neu.2011.2188 · DOI
- 10.1016/S0140-6736(14)60341-X · DOI
- 10.1016/j.jneuroim.2010.05.015 · DOI · Paper page
- 10.1016/S0165-0173(99)00007-7 · DOI
- 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P · DOI
- 10.1523/JNEUROSCI.4469-04.2005 · DOI
- 10.1093/brain/awp148 · DOI
- 10.1016/j.brainres.2009.06.054 · DOI
- 10.1002/hep.22952 · DOI
- 10.1038/ni1309 · DOI
- 10.1016/j.immuni.2013.02.012 · DOI · Paper page
- 10.1016/j.neubiorev.2012.02.013 · DOI · Paper page
- 10.1089/neu.1995.12.169 · DOI · Paper page
- 10.4049/jimmunol.0802812 · DOI
- 10.1186/1742-2094-2-24 · DOI
- 10.1038/jcbfm.2013.146 · DOI · Paper page
- 10.3389/fneur.2013.00018 · DOI
- 10.1073/pnas.0937239100 · DOI
- 10.1371/journal.pone.0034504 · DOI · Paper page
- 10.1016/j.nurt.2009.10.016 · DOI
Cited by
Sorted by citations
Items 101–200 of 212
Ciechanowska, A., & Mika, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073788 · Cited by 46
“Importantly, recent studies have shown that blocking CCR2 with the new antagonist CCX872 immediately after TBI is highly beneficial because it reduces the type I IFN response [272] and blocks the influx of CCR2 + macrophages [226] in acutely injured brain tissue in mice.”
BackgroundGao, S., Jiang, Y., Chen, Z., Zhao, X.-Q., Gu, J., Wu, H., Liao, Y., Sun, H., Wang, J., & Chen, W. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221216162606 · Cited by 51
“Significant recruitment of monocytes to the brain has been reported in neuroinflammatory diseases, such as traumatic brain injury, intracerebral hemorrhage, epilepsy, and autoimmune encephalomyelitis [39-42].”
BackgroundRoadmap for Advancing Pre-Clinical Science in Traumatic Brain Injury
Smith, D. H., Kochanek, P. M., Rosi, S., Meyer, R., Ferland‐Beckham, C., Prager, E. M., Ahlers, S. T., & Crawford, F. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2021.0094 · Cited by 46
“Moreover, it has been reported that this peripheral trafficking of proinflammatory monocytes in TBI can be treated with a CCR2 antagonist.(59) Altogether, these studies implicate the peripheral immune system as a key target for probing TBI pathology and its treatment.”
BackgroundMethodInfluentialSelf-citationMonocyte mobilisation, microbiota & mental illness
van de Wouw, M., Boehme, M., Dinan, T. G., & Cryan, J. F. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.019 · Cited by 41
Tarudji, A. W., Gee, C. C., Romereim, S. M., Convertine, A. J., & Kievit, F. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120766 · Cited by 40
The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis
Hansell, C. A. H., Fraser, A. R., Hayes, A. J., Pingen, M., Burt, C. L., Lee, K. M., Medina‐Ruiz, L., Brownlie, D., MacLeod, M. K. L., Burgoyne, P., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800131 · Cited by 45
“We also examined effects of a well-characterized pharmacological blocker of CCR2 (28, 29) on metastasis development.”
BackgroundMicroglia as therapeutic targets after neurological injury: strategy for cell therapy
Scott, M. C., Bedi, S. S., Olson, S. D., Sears, C. M., & Cox, C. S. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1934447 · Cited by 43
“This CCL2-CCR2 axis is a chemokine-receptor signaling pathway [105,106].”
BackgroundInfluentialPotential immunotherapies for traumatic brain and spinal cord injury
Putatunda, R., Bethea, J. R., & Hu, W.-H. (2018) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2018.02.002 · Cited by 46
Zhao, J., Hylin, M. J., Kobori, N., Hood, K. N., Moore, A. N., & Dash, P. K. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5102 · Cited by 79
“Studies have shown that TBI activates resident microglia, as well as causes infiltration of monocytes/neutrophils, resulting in an increase in the expression of MI and M2 markers, 80,81 and can contribute to neuronal injury.”
Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury
Xu, P., Zhang, F., Chang, M., Zhong, C., Sun, C., Zhu, H., Yao, J., Li, Z., Li, S.-T., Zhang, W.-C., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02115-0 · Cited by 49
“A recent study demonstrated that CCX872, a selective CCR2 antagonist, could decrease the accumulation of M1-type macrophages, and further improve the cognitive dysfunction caused by traumatic brain injury [10].”
BackgroundKomiya, H., Takeuchi, H., Ogawa, Y., Hatooka, Y., Takahashi, K., Katsumoto, A., Kubota, S., Nakamura, H., Kunii, M., Tada, M., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-00607-3 · Cited by 38
Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways
Sherawat, K., & Mehan, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02476-8 · Cited by 34
CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post‐Injury
Jablonski, C., Leonard, C., Salo, P., & Krawetz, R. (2019) · Journal of Orthopaedic Research · doi:10.1002/jor.24444 · Cited by 34
“, 1–7 days after FTCD injury), as macrophage levels are typically known to peak during the acute injury phase before returning to basal levels.(25,27,38,39) It would also be important to examine it there was any impacts on macrophage function in these stains as marker expression alone may not provide a complete picutu…”
BackgroundMurugan, M., Ravula, A. R., Gandhi, A., Vegunta, G., Mukkamalla, S., Mujib, W., & Chandra, N. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.029 · Cited by 33
Neuroimmune and neuroinflammation response for traumatic brain injury
Wu, J., Ren, R., Chen, T., Su, L., & Tang, T. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111066 · Cited by 32
“Another group found that the CCX872 (CCR2 antagonist) reduced peripheral macrophage accumulation in the brain as well as changed the regulation of multiple anti-inflammatory and pro-inflammatory cytokines after cortical control shocks (Morganti et al., 2015).”
Katsumoto, A., de Miranda, A. S., Butovsky, O., Teixeira, A. L., Ransohoff, R. M., & Lamb, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1075-y · Cited by 39
Littlejohn, E. L., Scott, D., & Saatman, K. E. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00925-6 · Cited by 34
“To measure spatial reference memory and learning, mice were tested using an established 2-day RAWM acquisition protocol [57, 58] beginning 39 dpi by an observer blinded to animal genotype.”
Saxena, S., Lai, I. K., Li, R., & Maze, M. (2019) · British Medical Bulletin · doi:10.1093/bmb/ldz010 · Cited by 37
“Treatment with CCX872, a novel CCR2 selective antagonist, significantly reduces TBI-induced accumulation of inflammatory macrophage, multiple proinflammatory and neurotoxic mediators and hippocampal-dependent cognitive dysfunction.(61)”
BackgroundHaar, C. V., Ferland, J. N., Kaur, S., Riparip, L., Rosi, S., & Winstanley, C. A. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14123 · Cited by 35
“This includes pro- and anti-inflammatory cytokines, as well as microglia activation (Holmin & Mathiesen, 1999; Shultz et al., 2012; Morganti et al., 2015, 2016; Vonder Haar et al., 2016).”
BackgroundSelf-citationGoulding, D. S., Vogel, R. C., Gensel, J. C., Morganti, J. M., Stromberg, A. J., & Miller, B. A. (2020) · Journal of Neurosurgery Pediatrics · doi:10.3171/2020.5.peds20124 · Cited by 34
Self-citationCXCR2 Blockade Mitigates Neural Cell Injury Following Preclinical Chorioamnionitis
Yellowhair, T. R., Newville, J., Noor, S., Maxwell, J. R., Milligan, E. D., Robinson, S., & Jantzie, L. L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00324 · Cited by 31
A polarizing view on posttraumatic brain injury inflammatory response
Rosi, S. (2016) · Brain Circulation · doi:10.4103/2394-8108.192517 · Cited by 35
“Brain Circulation - Vol 2, Issue 3, July 2016 127 TBI[16] was used to characterize the temporal inflammatory profiles following trauma at various succeeding time points.”
BackgroundMethodInfluentialSelf-citationBalan, I. S., Aurelian, L., Williams, K. S., Campbell, B., Meeker, R. B., & Morrow, A. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940095 · Cited by 33
Xu, J., Ganguly, A., Zhao, J., Ivey, M., Lopez, R., Osterholzer, J. J., Cho, C. S., & Olszewski, M. A. (2021) · mBio · doi:10.1128/mbio.01076-21 · Cited by 37
Frontal Lobe Contusion in Mice Chronically Impairs Prefrontal-Dependent Behavior
Chou, A., Morganti, J. M., & Rosi, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151418 · Cited by 34
“TBI was induced in the frontal lobe using the controlled cortical impact (CCI) model [21].”
MethodSelf-citationInterleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice
Chung, J. Y., Krapp, N., Wu, L., Lüle, S., McAllister, L. M., Edmiston, W. J., Martin, S. P., Levy, E. S., Songtachalert, T., Sherwood, J. S., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5659 · Cited by 32
Arfaei, R., Mikaeili, N., Daj, F., Boroumand, A., Kheyri, A., Yaraghi, P., Shirzad, Z., Keshavarz, M., Hassanshahi, G., Jafarzadeh, A., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112328 · Cited by 27
Chou, A., Espin, A. T., Huie, J. R., Krukowski, K., Lee, S., Nolan, A., Guglielmetti, C., Hawkins, B. E., Chaumeil, M. M., Manley, G. T., et al. (2022) · Neurotrauma Reports · doi:10.1089/neur.2021.0061 · Cited by 32
“To demonstrate the multi-data-set analytic workflow facilitated by the ODC-TBI, we aggregated data from three controlled cortical impact studies (i.e., independent experimental cohorts of animals; N = 99) published in Chou and colleagues [2018] and Morganti and colleagues [2015] 33,34 ).”
BackgroundMethodInfluentialSelf-citationMorrow, A. L., Boero, G., & Balan, I. S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105558 · Cited by 31
Zhang, X., Cui, H. L., Shu-mei, Z., Lu, Y., Yuan, H., Zhang, L., Wang, H., & Du, R. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148516 · Cited by 24
Wang, W., Prajapati, P., Vekaria, H. J., Spry, M. L., Cloud, A. L., Sullivan, P. G., & Springer, J. E. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.293149 · Cited by 29
“In support of this, experimental approaches that mitigate pro-inflammatory signaling after severe TBI can significantly reduce tissue pathology and promote functional recovery (Lloyd et al., 2008; Hsieh et al., 2014; Bachstetter et al., 2015; Morganti et al., 2015).”
BackgroundSeo, J. H., Dalal, M. S., Calderón, F. H., & Contreras, J. E. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01917-y · Cited by 28
Timaru‐Kast, R., Gotthardt, P., Luh, C., Huang, C., Hummel, R., Schäfer, M. K. E., & Thal, S. C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00063 · Cited by 28
Zhang, M., Wu, Y.-Q., Xie, L., Teng, C., Wu, F., Xu, K., Chen, X., Xiao, J., Zhang, H.-Y., & Chen, D.-Q. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.09.046 · Cited by 25
Quarta, A., Blon, D. L., D’aes, T., Pieters, Z., Taj, S. H., Miró‐Mur, F., Luyckx, E., Breedam, E. V., Daans, J., Goossens, H., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.009 · Cited by 29
The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy
Makinde, H. M., Just, T. B., Cuda, C. M., Perlman, H., & Schwulst, S. J. (2017) · Shock · doi:10.1097/shk.0000000000000859 · Cited by 24
Castranio, E. L., Wolfe, C. M., Nam, K. N., Letronne, F., Fitz, N. F., Lefterov, I., & Koldamova, R. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0569-2 · Cited by 23
“mation and inflammatory molecules are strongly correlated with multiple measures of outcome in patients, including neurobehavioral impairments and survival rates [29, 45].”
Zaltsman, S. L., Friedman‐Levi, Y., Shabashov-Stone, D., Gincberg, G., Atrakcy-Baranes, D., Joy, M. T., Carmichael, S. T., Silva, A. J., & Shohami, E. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7015 · Cited by 34
“43,44 One of the key signal transduction pathways responsible for cell survival and proliferation is the Ras-dependent Erk1/2 MAPK pathway.”
Dickerson, M. R., Bailey, Z. S., Murphy, S. F., Urban, M. J., & VandeVord, P. J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00618 · Cited by 23
“Studies have emerged reporting that CCR2-dependent macrophages are recruited from the periphery then dissipate in the early chronic stages of injury (75, 76).”
BackgroundKjell, J., & Götz, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00032 · Cited by 29
Bennett, M., Chin, A., Lee, H. J., Cestero, E. M., Strazielle, N., Ghersi‐Egea, J., Threlkeld, S. W., Schmidt, T. A., Richendrfer, H. A., Szmydynger‐Chodobska, J., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7229 · Cited by 25
Goulding, D. S., Vogel, R. C., Pandya, C. D., Shula, C., Gensel, J. C., Mangano, F. T., Goto, J., & Miller, B. A. (2020) · Journal of Neurosurgery Pediatrics · doi:10.3171/2019.12.peds19625 · Cited by 35
A data-driven approach for evaluating multi-modal therapy in traumatic brain injury
Haefeli, J., Ferguson, A. R., Bingham, D., Orr, A., Won, S. J., Lam, T. I., Shi, J., Hawley, S., Liu, J., Swanson, R. A., et al. (2017) · Scientific Reports · doi:10.1038/srep42474 · Cited by 23
Self-citationThe contribution of the meningeal immune interface to neuroinflammation in traumatic brain injury
Mokbel, A. Y., Burns, M. P., & Main, B. S. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03122-7 · Cited by 25
“Indeed, modulation of the CCR2-CCL2 signaling axis in TBI has been shown to be beneficial [77, 318–320].”
BackgroundThe therapeutic potential of bone marrow‐derived macrophages in neurological diseases
Zhou, K., Han, J., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13964 · Cited by 44
Wang, H., Huang, Q., Zhang, Z., Ji, J., Sun, T., & Wang, D. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02535-6 · Cited by 20
“Different studies have shown that targeting CCR2 or its ligands can inhibit monocyte chemotaxis and improve short- and long-term outcomes [7, 8].”
BackgroundChen, M., Chen, Q., & Tao, T. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s265478 · Cited by 22
Paladini, M. S., Yang, B. A., Torkenczy, K. A., Frias, E. S., Feng, X., Krukowski, K., Sit, R. V., Morri, M., Lam, W., Pedoia, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63952-8 · Cited by 22
“Such experiments would provide robust evidence linking MDM persistence to cognitive impairments and strengthen the translational relevance of the findings.”
InfluentialSelf-citationChemokines in neurodegenerative diseases
Vida, H., Sahar, M., Nikdouz, A., & Hosseini, A. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12843 · Cited by 22
“72 Although CCL2 plays a crucial role in the pathogenesis of MS, Kaushansky et al .”
Modelling physical resilience in ageing mice
Schosserer, M., Banks, G. T., Doğan, S., Dungel, P., Fernandes, A. M. A., Marolt, D., Matheu, A., Osuchowski, M. F., Potter, P. K., Sanfeliu, C., et al. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.10.001 · Cited by 21
G-protein coupled receptors in neuroinflammation, neuropharmacology, and therapeutics
Singh, A. P., Shadangi, S., & Rana, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117301 · Cited by 16
Eliasberg, C. D., Carballo, C. B., Piacentini, A. N., Caughey, S., Havasy, J., Khan, M., Liu, Y., Ivasyk, I., & Rodeo, S. A. (2023) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.22.01160 · Cited by 19
Insights from experimental post-thrombotic syndrome and potential for novel therapies
Henke, P. K., Sharma, S. B., Wakefield, T. W., Myers, D. D., & Obi, A. T. (2020) · Translational research · doi:10.1016/j.trsl.2020.05.005 · Cited by 16
The NOX2-ROS-NLRP3 inflammasome axis in traumatic brain injury
Laabei, J., Vegliante, G., Strogulski, N. R., Douglas, C., Threja, S., Pearson, A., Nkiliza, A., Hanscom, M., Emediato, I. D. F., Crawford, F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03535-y · Cited by 17
“Furthermore, CCR2 antagonism blocks monocytes infiltration and alters the lesion microenvironment by reducing NOX2 expression [36, 48], which can reduce motor and cognitive deficits induced by TBI [36, 48].”
Giordano, K. R., Saber, M., Green, T. R. F., Rojas-Valencia, L. M., Ortiz, J. B., Murphy, S. M., Lifshitz, J., & Rowe, R. K. (2023) · Neurotrauma Reports · doi:10.1089/neur.2022.0092 · Cited by 12
“Blood–brain barrier damage and cytokine signaling from central immune cells leads to infiltration of neutrophils and monocyte-derived macrophages into the parenchyma and continued cytokine signaling, which perpetuates immune cell activation, creating a feedforward loop.(6,7) Acutely after injury, microglia and monocyt…”
BackgroundCCR2 downregulation attenuates spinal cord injury by suppressing inflammatory monocytes
Zhang, Q., Zhu, C., Li, X., Shi, Y., & Zhang, Z. (2020) · Synapse · doi:10.1002/syn.22191 · Cited by 15
“Similar to SCI, mice following TBI also showed accumulation of CCR2-positive macrophages derived from peripheral blood.”
BackgroundInfluentialRepetitive injury and absence of monocytes promote astrocyte self‐renewal and neurological recovery
Canhos, L. L., Chen, M., Falk, S., Popper, B., Straub, T., Götz, M., & Sirko, S. (2020) · Glia · doi:10.1002/glia.23893 · Cited by 19
“The functional contribution of CCR2 to TBI pathology has been related to the over-all reduced inflammatory state, smaller lesion size and decrease in the number of apoptotic cells and reactive astrogliosis as measured by GFAP immunoreactivity (Chu et al., 2014; Morganti et al., 2015).”
Khodaei, S., Avramescu, S., Wang, D.-S., Sheng, H., Chan, N. K., Lecker, I., Fernandez-Escobar, A., Lei, G., Dewar, M. B., Whissell, P. D., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004161 · Cited by 14
“TBI induces long-lasting inflammation in the brain (22), which could increase cell surface expression of α5GABA A receptors.”
BackgroundChompré, G., Martínez‐Orengo, N., Cruz, M. L., Porter, J. T., & Noel, R. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1664-4 · Cited by 17
Stem Cell Therapy for Sequestration of Traumatic Brain Injury-Induced Inflammation
Borlongan, M. C., & Rosi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810286 · Cited by 15
“Moreover, we dissected the key contribution of CCR2(+) macrophages to the resulting neuroinflammation in response to TBI [35].”
BackgroundResultInfluentialSelf-citationBlon, D. L., Hoornaert, C., Detrez, J. R., Bevers, S., Daans, J., Goossens, H., Vos, W. H. D., Berneman, Z. N., & Ponsaerts, P. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2188 · Cited by 14
“Another study in amousemodel for traumatic brain injury (TBI) demonstrated that there is a temporal difference in the appearance of brain-resident microglia and infiltrating macrophages (Morganti et al., 2015).”
BackgroundDai, B., ZHENG, L., Cheung, J. C., Yufeng, L. O. N. G., Liu, J., Wen, C., Qin, L., & Cheng, D. O. N. G. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124063 · Cited by 15
Neuroimmune dynamics and cytokines in traumatic brain injury
Davis, A. C., & Godbout, J. P. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.09.009 · Cited by 13
Research Progress on the Inflammatory Effects of Long Non-coding RNA in Traumatic Brain Injury
Wang, J., Li, C., Ding, W., Peng, G., Xiao, G., Chen, R., & Cheng, Q. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.835012 · Cited by 14
“However, the inhibition of monocyte infiltration into the brain alleviates secondary injury and promotes the recovery of cognitive function (Morganti et al., 2015).”
BackgroundQuarta, A., Berneman, Z. N., & Ponsaerts, P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0820-536r · Cited by 17
Macheda, T., Roberts, K. N., Morganti, J. M., Braun, D. J., & Bachstetter, A. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232862 · Cited by 16
“For instance, TBI-induced deficits have been reported following a CCI using a two-day RAWM protocol [40, 41], and three-day RAWM protocol [42].”
MethodSelf-citationInhibition of MALT1 paracaspase activity improves lesion recovery following spinal cord injury
Zhang, H., Sun, G., Li, X., Fu, Z. F., Guo, C., Cao, G., Wang, B., Wang, Q., Yang, S., Li, D., et al. (2019) · 中国科学通报:英文版 · doi:10.1016/j.scib.2019.04.026 · Cited by 11
Fang, S., Tang, H., Li, H.-L., Han, T.-Y., Li, Z.-J., Yin, Z.-S., & Chu, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03641-z · Cited by 10
“In addition, the selective CCR2 antagonist CCX872 reduced M1-type macrophage accumulation and further improved cognitive dysfunction induced by traumatic cerebrospinal cord injury [23].”
The role of the immune system during regeneration of the central nervous system
Sabin, K. Z., & Echeverri, K. (2019) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2019.100023 · Cited by 10
Baassiri, M. G. E., Raouf, Z., Jang, H., Scheese, D. J., Duess, J. W., Fulton, W. B., Sodhi, C. P., Hackam, D. J., & Nasr, I. W. (2024) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004246 · Cited by 11
“33 Another study by Morganti et al. 34 found that targeting Ccr2 + monocytes using CCX872, a novel phase 1 Ccr2 selective antagonist, significantly reduced the expression of proinflammatory and neurotoxic markers and improved cognitive outcomes.”
Kii, N., Sawada, A., Yoshikawa, Y., Tachibana, S., & Yamakage, M. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005699 · Cited by 11
Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective
Arimitsu, N. N., Witkowska, A., Ohashi, A., Miyabe, C., & Miyabe, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1547256 · Cited by 6
Azithromycin reduces hemoglobin-induced innate neuroimmune activation
Pandya, C. D., Vekaria, H. J., Zamorano, M., Trout, A. L., Ritzel, R., Guzman, G., Bolden, C., Sullivan, P. G., Gensel, J., & Miller, B. A. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114574 · Cited by 7
“( Goulding et al., 2020; Morganti et al., 2015) Since IVH occurs very early in patients ’ lives, (Perlman and Volpe, 1986) the issue of safety in neonates is of paramount importance.”
BackgroundQuarta, A., Meese, T., Pieters, Z., Breedam, E. V., Blon, D. L., Broeckhoven, J. V., Hendrix, S., Goossens, H., Hens, N., Berneman, Z. N., et al. (2020) · Glia · doi:10.1002/glia.23899 · Cited by 17
“…processes, blood-derived monocytes/macrophages can also colonize the neuroinflammatory environment when the blood brain barrier is compromised (Ajami, Bennett, Krieger, McNagny, & Rossi, 2011; Hamzei Taj et al., 2018; Morganti et al., 2015; Ritzel et al., 2015; Yamasaki et al., 2014).”
BackgroundIntravital Imaging of Myeloid Cells: Inflammatory Migration and Resident Patrolling
Deniset, J., & Kubes, P. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0042-2016 · Cited by 8
“Interestingly, the latest studies have argued that monocytes may be at least as important as neutrophils in inducing brain inflammation (91, 92).”
Wells, A., Varanoske, A. N., Coker, N., Kozlowski, G. J., Frosti, C. L., Boffey, D., Harat, I., Jahani, S., Gepner, Y., & Hoffman, J. (2020) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003809 · Cited by 6
“This hypothesis was driven by research, indicating MCP-1 and CCR2 are directly associated with cognitive outcomes in a number of inflammatory conditions (16,30,36).”
BackgroundMethodThe NOX2-ROS-NLRP3 inflammasome axis in traumatic brain injury
Laabei, J., Vegliante, G., Strogulski, N., Douglas, C., Threja, S., Pearson, A., Nkiliza, A., Hanscom, M., Emediato, I. D. F., Crawford, F., et al. (2025) · bioRxiv · doi:10.1101/2025.05.16.654460 · Cited by 5
Akhter, N., Contreras, J., Ansari, M. A., Ducruet, A. F., Hoda, M. N., Ahmad, A. S., Gangwani, L., Bhatia, K., & Ahmad, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413626 · Cited by 6
“Moreover, peripheral macrophages also actively participate in the acute neuroinflammatory cascade [22].”
Zhang, Y., Zhao, Y., Wang, Y., Li, J., Huang, Y., Lyu, F., Wang, Y., Wei, P., Yuan, Y., Fu, Y., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231197173 · Cited by 7
“Monocyte-derived macrophages have been reported to hinder functional recovery in spinal cord injury and TBI; 22,72 however, whether macrophages and microglia work independently or synergistically remains unclear.”
BackgroundInfluentialAutophagy in neuroinflammation after traumatic brain injury
Sarkar, C., & Lipinski, M. M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382247 · Cited by 5
“…of pro-inflammatory markers like NOS2/iNOS (nitric oxide synthase 2, inducible), NLRP3, and CYBB/NOX2 (cytochrome b-245, beta polypeptide) and cytokines like tumor necrosis factor-α and interleukin-1β (Morganti et al., 2015), indicating that inhibition of autophagy is associated with inflammation.”
BackgroundSharma, R., Chu, E., Dill, L. K., Shad, A., Zamani, A., O'Brien, T. J., Casillas-Espinosa, P. M., Shultz, S. R., & Semple, B. D. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2022.0033 · Cited by 5
“As pre-clinical studies in adult TBI models have demonstrated neuroprotection afforded by blocking or impairing the infiltration of CCR2 + macrophages into the injured brain, 49,52,76,98 this hypothesis still warrants further investigation.”
Rosi, S., & Feng, X. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.202940 · Cited by 5
“CCR2 is a chemokine receptor expressed in blood derived monocytes but not in brain resident microglia (Morganti et al., 2015) and activation of the CCR2-CCL2 signaling axis has been shown to recruit CCR2-expressing monocytes (“inflammatory monocytes”) into the injured tissue where they become activated macrophages, ex…”
BackgroundSelf-citationNemeth, D. P., Liu, X., Chen, L., Hawkins, M. R., Ali, H. S., Lapid, M. G., Farsian, V., Kim, A., Saez, J., Maxey, G., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106177 · Cited by 3
Modulation of microglia activation by the ascorbic acid transporter SVCT2
Marino, A. L., Rex, T. S., & Harrison, F. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.003 · Cited by 9
“Microglia respond rapidly follow mTBI with changes reported within 24 h following injury (Morganti et al., 2015; Donat et al., 2017).”
Du, Q., Liu, C., Liu, Y., Li, J., Gong, X., Zhang, Q., & Li, K. (2023) · International Emergency Nursing · doi:10.1016/j.ienj.2023.101313 · Cited by 21
Natakusuma, T. I. S. D., Mahadewa, T. G. B., Mardhika, P. E., Maliawan, S., Senapathi, T. G. A., & Ryalino, C. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6985 · Cited by 5
“Monocytes accumulate in the injured area up to 3 days after the onset of TBI and cause neurotrophic and neurotoxic effects [21], [22].”
BackgroundChou, A., Espin, A. T., Huie, J., Krukowski, K., Lee, S., Nolan, A. L., Guglielmetti, C., Hawkins, B. E., Chaumeil, M., Manley, G., et al. (2021) · bioRxiv · doi:10.1101/2021.03.15.435178 · Cited by 4
“independent experimental cohorts of animals) published in Chou et al 2018 and Morganti et al 2015 [32,35].”
BackgroundMethodResultInfluentialSelf-citationThomasy, H. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2799-16.2016 · Cited by 4
“…chronic cognitive dysfunction, including impaired LTP (Titus et al., 2013), cholinergic (Arciniegas, 2003) and catecholaminergic (Jenkins et al., 2016) signaling disturbances, neuroinflammation (Morganti et al., 2015), and dysfunctions of white matter and neural connectivity (Hayes et al., 2016).”
BackgroundDavis, A. C., Goodman, E. J., Wangler, L. M., Packer, J. M., Thammachack, R., Yildiz, V. O., Sharma, P., Pietrzak, M., Xiaokui, M., Quan, N., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106524 · Cited by 3
Temporal and Spatial Patterns of Glial Activation After Unilateral Cortical Injury in Rats
Rich, K. K., Hjæresen, S., Andersen, M. S., Hansen, L. B., Mohammad, A. S., Gopinathan, N., Mogensen, T. C., Svenningsen, Å. F., & Zhang, M. (2026) · Life · doi:10.3390/life16010142 · Cited by 2
“Although cytokines were not assessed here, prior studies show that CD11b + cells are rapidly recruited to injury sites, where they participate in debris clearance and inflammatory signaling [18–20].”
InfluentialLin, Y.-W., Jin, J., Han, Q., Hang, D., Chen, Z., Ye, S., Guo, Q., Huang, X.-Y., Li, J.-N., Zhang, H., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166618 · Cited by 3
Yan, W., Mengke, W., Su, Z., Gu, J., & Guan, F. (2024) · Acta Neurologica Belgica · doi:10.1007/s13760-024-02537-6 · Cited by 2
“Neutrophils not only clear debris such as myelin debris, but also aggravate inflammation and even lead to neuronal loss [44].”
Nieves, M. D., Furmanski, O., & Doughty, M. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24766 · Cited by 5
“Interrupted signaling of either chemokine pathway generally benefits the brain by decreasing lesion volume and promoting recovery (Israelsson et al., 2014; Morganti et al., 2015).”
BackgroundRosi, S. (2017) · Brain Circulation · doi:10.4103/bc.bc_25_17 · Cited by 2
“[12] CCR2 is a chemokine receptor absent from brain microglia[2] and the stimulation of CCR2-CCL2 signaling causes the accumulation of CCR2-expressing monocytes (also known as “inflammatory monocytes”) in the injured tissue.”
BackgroundSelf-citationHelmbrecht, H., Ardalan, M., Kelly, L. A., Robinson, S., Fleiss, B., Doherty, D. G., Gressèns, P., Mallard, C. E., Molloy, E. J., & Jantzie, L. L. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03900-5 · Cited by 3
“Typically, neutrophil influx is a secondary response after brain injury, which further exacerbates endogenous inflammation mediated by microglia [155, 192–195].”
Li, X., Xu, Z., Fang, J., & Huang, H. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1641112 · Cited by 1
Taylor, M. A., Boland, R., Houle, S., Tapp, Z. M., Davis, A. C., Cotter, C., Sheridan, J. F., Godbout, J., & Kokiko‐Cochran, O. N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1689773 · Cited by 1
Wei, Y., Ming-li, S. U., Ren, D.-L., Zhang, X., Zhu, T., & Yan, X. (2024) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2024.04.004 · Cited by 1
Uemura, E., Tajima, G., Murahashi, S., Matsumoto, N., Tokunaga, A., Miura, M., Murase, T., Ikematsu, K., & Tasaki, O. (2020) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0000000000003041 · Cited by 1
“This chemokine receptor plays an important role in the recruitment of macrophages to damaged tissues and their activation.(27,28) It was reported that the amounts of CD11b+CCR2+ cells and the number of macrophages infiltrating an injured site from the periphery temporarily increase and induce inflammation within 12 to…”
BackgroundIannucci, J., Sentmanat, A., Dickerson, K., Obaid, M., Bandopadhyay, S., Houghton, A., Arisi, G. M., & Shapiro, L. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209127
“CCL2 signaling through its receptor CCR2 helps regulate monocyte entry into the brain after TBI [225], and CCR2-associated macrophage responses are increased after injury [226–228].”
Metadata
- Authors
- Morganti, J. M., Jopson, T. D., Liu, S., Riparip, L.-K., Guandique, C. K., Gupta, N., Ferguson, A. R., & Rosi, S.
- Affiliations
- University of California, San Francisco (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2015-01-14
- Volume
- 35
- Issue
- 2
- Pages
- 748-760
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4293420
- OpenAlex
- W2140178129
- Cited by
- 253
- References
- 71
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 17 · 2023: 15 · 2022: 21 · 2021: 30 · 2020: 35 · 2019: 26 · 2018: 32 · 2017: 19 · 2016: 23 · 2015: 10
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Alzheimer's Association (IIRG-11-202064)
- National Institutes of Health
- National Institute on Aging (R21AG042016)
- National Cancer Institute (R01CA133216)
- National Institute of Neurological Disorders and Stroke (R21NS087458, R01NS067092, F32NS090805)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Keywords
- traumatic brain injury, CCR2+ macrophages, macrophage polarization, neuroinflammation, cognitive impairment, hippocampus, monocytes, secondary injury, pro-inflammatory mediators
- MeSH terms
- CX3C Chemokine Receptor 1, Animals, Brain Injuries, Cognition, Female, Hippocampus, Macrophage Activation, Macrophages, Male, Mice, Inbred C57BL, Receptors, Chemokine, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review